June 23, 2026 3 E Network Technology Group Limited Announces Initial Closing of US$2 Million Convertible Promissory Note Offering
June 23, 2026 Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
June 23, 2026 Castellum to Present at Maxim Group Defense Tech and Domestic Supply Chain Virtual Conference on June 25
